|
ARHGAP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.30389999972469E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.76690000000634E-06 |
| Normal-vs-Stage2 |
7.715800E-03 |
| Normal-vs-Stage3 |
8.475200E-03 |
| Normal-vs-Stage4 |
2.094400E-02 |
| Stage1-vs-Stage2 |
7.240400E-01 |
| Stage1-vs-Stage3 |
8.970800E-01 |
| Stage1-vs-Stage4 |
7.742600E-01 |
| Stage2-vs-Stage3 |
8.533400E-01 |
| Stage2-vs-Stage4 |
9.856000E-01 |
| Stage3-vs-Stage4 |
8.646800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.18100000001675E-07 |
| Normal-vs-AfricanAmerican |
7.683900E-03 |
| Normal-vs-Asian |
1.258310E-03 |
| Caucasian-vs-AfricanAmerican |
1.783000E-01 |
| Caucasian-vs-Asian |
6.894000E-01 |
| AfricanAmerican-vs-Asian |
4.065600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.3104999996294E-07 |
| Normal-vs-Female |
5.124500E-03 |
| Male-vs-Female |
1.891760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.448510E-04 |
| Normal-vs-Extreme_Weight |
1.76390999999665E-05 |
| Normal-vs-Obese |
4.262900E-03 |
| Normal-vs-Extreme_Obese |
4.550200E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.185400E-01 |
| Normal_Weight-vs-Obese |
2.413200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.259400E-01 |
| Extreme_Weight-vs-Obese |
2.706600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.276400E-01 |
| Obese-vs-Extreme_Obese |
7.215000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.936600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.564000E-03 |
| Normal-vs-Age(61-80Yrs) |
3.1768000452459E-09 |
| Normal-vs-Age(81-100Yrs) |
2.283600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.230800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.266300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.723600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.720200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.108190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.751200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.227200E-04 |
| Normal-VS-Type2 PRCC |
9.48190415073213E-11 |
| Normal-VS-KIRP CIMP |
6.683000E-01 |
| Normal-VS-Unclassified PRCC |
1.949710E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.170030E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.382800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.844200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.187220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.998100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.585600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.50170045474385E-10 |
| Normal-vs-N1 |
1.790420E-01 |
| Normal-vs-N2 |
2.77699999995384E-06 |
| N0-vs-N1 |
2.757700E-02 |
| N0-vs-N2 |
2.219600E-01 |
| N1-vs-N2 |
9.856300E-02 |
|
|
